CCM
OGN icon

Copeland Capital Management’s Organon & Co OGN Stock Holding History

Copeland Capital Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-60
Closed -$2K – 291
2022
Q4 		$2K Hold
60
– – ﹤0.01% 270
2022
Q3 		$1K Hold
60
– – ﹤0.01% 278
2022
Q2 		$2K Hold
60
– – ﹤0.01% 262
2022
Q1 		$2K Hold
60
– – ﹤0.01% 268
2021
Q4 		$2K Hold
60
– – ﹤0.01% 269
2021
Q3 		$2K Hold
60
– – ﹤0.01% 268
2021
Q2 		$2K Buy
+60
New +$1.98K ﹤0.01% 269

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Copeland Capital Management's OGN Position: Q1 2023 in Review

Copeland Capital Management sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 60 shares — an estimated $2K sold.

Copeland Capital Management first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $2K in Q4 2022. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Copeland Capital Management reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Copeland Capital Management sold 60 Organon & Co shares in Q1 2023, an estimated $2K.
  • Copeland Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
  • Copeland Capital Management's Organon & Co position peaked at $2K in Q4 2022.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Copeland Capital Management's 13F filing for Q1 2023, filed 14 Apr 2023.